Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

pH-Sensitive Nano-Complexes Overcome Drug Resistance and Inhibit Metastasis of Breast Cancer by Silencing Akt Expression
Jieying Yin, Tianqun Lang, Dongmei Cun, et al.
Theranostics (2017) Vol. 7, Iss. 17, pp. 4204-4216
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4673-4673
Open Access | Times Cited: 113
Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis
He Wang, Fangke Zhang, Huaying Wen, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 107
Recent Advances in Stimulus‐Responsive Nanocarriers for Gene Therapy
Yu Cheng, Long Li, Pei Hu, et al.
Advanced Science (2021) Vol. 8, Iss. 14
Open Access | Times Cited: 95
Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy
Cong Xu, Liu Wan, Yuan Hu, et al.
Theranostics (2020) Vol. 10, Iss. 7, pp. 3325-3339
Open Access | Times Cited: 88
Nanomedicines inhibiting tumor metastasis and recurrence and their clinical applications
Xiangyi Kong, Ran Cheng, Jing Wang, et al.
Nano Today (2020) Vol. 36, pp. 101004-101004
Closed Access | Times Cited: 73
Oxaliplatin delivery via chitosan/vitamin E conjugate micelles for improved efficacy and MDR-reversal in breast cancer
Asif Mohd Itoo, Milan Paul, Balaram Ghosh, et al.
Carbohydrate Polymers (2022) Vol. 282, pp. 119108-119108
Closed Access | Times Cited: 66
CRISPR-Cas9 Gene Therapy: Non-Viral Delivery and Stimuli-Responsive Nanoformulations
Hyun-Woo Lee, Won‐Yeop Rho, Yoon-Hee Kim, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 542-542
Open Access | Times Cited: 1
Recent Advances in RNA Therapeutics and RNA Delivery Systems Based on Nanoparticles
Hojeong Shin, S.D. Park, Yeajee Yim, et al.
Advanced Therapeutics (2018) Vol. 1, Iss. 7
Closed Access | Times Cited: 78
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
Ranga Dissanayake, Rheal A. Towner, Marya Ahmed
Cancers (2023) Vol. 15, Iss. 11, pp. 2906-2906
Open Access | Times Cited: 17
Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways
Yanfei Liu, Zhiqiang Feng, Tianhao Chu, et al.
Phytomedicine (2024) Vol. 126, pp. 155462-155462
Closed Access | Times Cited: 6
Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
Liwei Lang, Chloe Shay, Yuanping Xiong, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 56
Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer
Gang Chen, Yixin Wang, Pengkai Wu, et al.
ACS Nano (2018) Vol. 12, Iss. 7, pp. 6620-6636
Closed Access | Times Cited: 54
Nano-bio interactions: A major principle in the dynamic biological processes of nano-assemblies
Jing Liu, Mengyu Guo, Chunying Chen
Advanced Drug Delivery Reviews (2022) Vol. 186, pp. 114318-114318
Closed Access | Times Cited: 23
Progress of Cell‐Derived Biomimetic Drug Delivery Systems for Cancer Therapy
Tianqun Lang, Qi Yin, Yaping Li
Advanced Therapeutics (2018) Vol. 1, Iss. 7
Closed Access | Times Cited: 45
Overcoming Drug Resistance in Colon Cancer by Aptamer-Mediated Targeted Co-Delivery of Drug and siRNA Using Grapefruit-Derived Nanovectors
Wei Yan, Mingyue Tao, Baofei Jiang, et al.
Cellular Physiology and Biochemistry (2018) Vol. 50, Iss. 1, pp. 79-91
Open Access | Times Cited: 45
In Vivo Evaluation of Reduction-Responsive Alendronate-Hyaluronan-Curcumin Polymer-Drug Conjugates for Targeted Therapy of Bone Metastatic Breast Cancer
Kaili Wang, Chunjing Guo, Xue Dong, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 7, pp. 2764-2769
Closed Access | Times Cited: 42
Bleomycin-Loaded pH-Sensitive Polymer–Lipid-Incorporated Liposomes for Cancer Chemotherapy
Eiji Yuba, Tomohiro Osaki, Misato Ono, et al.
Polymers (2018) Vol. 10, Iss. 1, pp. 74-74
Open Access | Times Cited: 38
SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
Xiyu Liu, Jiang Wang, Ding Ma, et al.
Theranostics (2020) Vol. 10, Iss. 24, pp. 10940-10956
Open Access | Times Cited: 34
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro
Yuqi Yang, Ning Ji, Qiu‐Xu Teng, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 33
A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer
Chuanrong Chen, Ming Shen, Hongze Liao, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Emerging nanotaxanes for cancer therapy
Yachao Zhang, Wenjing Zhang, Yongqi Wang, et al.
Biomaterials (2021) Vol. 272, pp. 120790-120790
Closed Access | Times Cited: 32
Stapled Wasp Venom-Derived Oncolytic Peptides with Side Chains Induce Rapid Membrane Lysis and Prolonged Immune Responses in Melanoma
Ye Wu, Lu Dong, Yixin Jiang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 9, pp. 5802-5815
Closed Access | Times Cited: 31
Novel hyaluronic acid-modified temperature-sensitive nanoparticles for synergistic chemo-photothermal therapy
Ting Zhao, Shiwei Qin, Linna Peng, et al.
Carbohydrate Polymers (2019) Vol. 214, pp. 221-233
Closed Access | Times Cited: 33
In vitro effect of Pannexin 1 channel on the invasion and migration of I-10 testicular cancer cells via ERK1/2 signaling pathway
Haofeng Liu, Min Yuan, Yanxue Yao, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 117, pp. 109090-109090
Open Access | Times Cited: 33
Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor
Yuqi Yang, Ning Ji, Chao‐Yun Cai, et al.
Cancer Communications (2020) Vol. 40, Iss. 7, pp. 285-300
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top